Nathaniel Wang,
Head of R&D,
Synthetic Genomics
Dr. Wang is the Head of R&D for RNA Medicines at Synthetic Genomics, Inc. Dr. Wang received his PhD from The Scripps Research Institute and is an experienced scientist in cellular immunology and molecular genetics. Dr. Wang leads Discovery, Preclinical, and Process Development groups for a portfolio of immuno-oncology and infectious disease programs focused on RNA technologies. He has extensive experience relating to the molecular determinants of immunological memory formation following vaccination as well as design of immuno-oncology fixed regime therapies.
|
|
|